Source: Stock image generated with AI.

Key Highlights

  • Trading in MindBio Therapeutics Corp. shares resumed on the Canadian Securities Exchange.
  • The Canadian Investment Regulatory Organization set the resumption time at 11:15 am Eastern.
  • The notice did not disclose the reason for the earlier trading halt.

Trading in MindBio Therapeutics Corp. (CSE: MBIO) resumed on the Canadian Securities Exchange, according to a notice published by the Canadian Investment Regulatory Organization (CIRO).

CIRO listed the resumption time as 11:15 am Eastern on Nov. 5, 2026, and indicated the resumption applied to all issues of the company.

This article is a journalistic opinion piece which has been written based on independent research. It is intended to inform investors and should not be taken as a recommendation or financial advice.

The CIRO notice did not provide details on why trading had been halted before the resumption.

CIRO is Canadas national self-regulatory organization overseeing investment dealers and trading activity on debt and equity marketplaces, and it can impose temporary trading halts to support a fair and orderly market.

The original press release is available on stockhouse.com

More From The Market Online

Fairchild Gold outlines new Golden Arrow gold-silver targets from satellite survey

Fairchild Gold reported TerraEye satellite survey results at Golden Arrow in Nevada, outlining nine gold-silver targets and planned field verification.
TSX Jumps 2.28% as AI Stocks Slide, Wendy’s Fights Bid

Market Open: TSX Jumps 2.28% as AI Stocks Slide and Wendy’s Rejects Buyout | Nov 5th

The TSX jumped 2.28% while the Nasdaq fell 2.64% on an AI selloff, and Wendy’s rejected an activist buyout with a poison pill.

Mobix Labs reports six-figure aircraft engine-system production orders

Mobix Labs said it received new six-figure production orders for aircraft engine-system components from a tier-one aerospace and defence supplier.